<DOC>
	<DOCNO>NCT02989519</DOCNO>
	<brief_summary>The purpose study determine efficacy vaginal oral progesterone tocolytic therapy threaten preterm labor</brief_summary>
	<brief_title>Efficacy Oral Progesterone Vaginal Progesterone After Tocolytic Therapy Threatened Preterm Labor</brief_title>
	<detailed_description>A randomize control trial conduct August 2015 December 2016 . All pregnant woman single pregnancy 28 33 week 6 day experience threatened preterm labor intact membrane inclusion criterion approach ask enrollment . The gestational age patient confirm antenatal record review ultrasonographic confirmation . Threatened preterm labor define presence regular uterine contraction without significant cervical change determine digital pelvic examination . Preterm labor define simultaneous presence regular uterine contraction cervical change , shorten and/or softening , dilatation , determine digital pelvic examination . The woman preterm labor underwent standard tocolysis , administer least 48 hour , allow corticosteroid promote fetal lung maturation . The patient proven membrane rupture , ultrasonographically find placenta previa , multiple pregnancy , fetal anomaly aneuploidy would exclude . The participant emergency condition require emergency delivery fetal distress , chorioamnionitis also exclude . Participants randomize three group generate computer programme receive whether oral progesterone ( dydrogesterone 10 mg ; Duphaston™ ) per oral three time day vaginal progesterone ( micronized progesterone 200 mg ; Utrogestan™ ) progesterone ( control group ) . All patient digitally pelvic examined evaluation Bishop score assess cervical length transvaginal ultrasound enrollment follow visit two week apart . Cervical length measure standard technique cover probe insert vagina woman empty bladder . Excessive pressure cervix avoid . The mean value 3 consecutive measurement use analysis . Informed consent demographic data obtain enrollment . Primary outcome preterm delivery 34 37 week . Secondary outcome include time delivery ( latency period , day ) , change cervical length ( cervical attenuation ) , maternal outcome , neonatal outcome , side effect drug collect . The main outcome preterm delivery , gestational age parturition birthweight also collect telephone call case out-side-hospital born case loss follow . Monitoring patient evaluate every follow visit drug side effect , allergic response , adverse event Statistical analysis Sample size calculate accord result two study Dorota AgataBomba - Opon Manju Choudhary show significant decreased preterm delivery &lt; 34 week ( 9.8 % vs 35.3 % , p=0.002 ) vaginal progesterone group , significant decrease preterm birth ( 33 % vs 58 % ; p= 0.034 ) oral progesterone group . The sample size 231 use evaluate primary outcome drug . Descriptive statistic carry use mean , median , standard deviation , interquartile range . Categorical data test significance χ2tests . Continuous data evaluate normal distribution test significance ANOVA Kruskal-Wallis test . Student test Man-Whitney U test use test significance group case significant detection ANOVA Kruskal-Wallis test among group . Statistical significance define p &lt; 0.05 .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Obstetric Labor , Premature</mesh_term>
	<mesh_term>Dydrogesterone</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>Tocolytic Agents</mesh_term>
	<criteria>Single pregnancies 28 33 week 6 day experience threatened preterm labor intact membrane Proven membrane rupture Ultrasonographically find placenta previa , multiple pregnancy , fetal anomaly Aneuploidy detect . Had emergency condition require emergency delivery fetal distress , chorioamnionitis , prolapse cord</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>preterm labor</keyword>
	<keyword>progesterone efficacy</keyword>
	<keyword>threaten preterm labor</keyword>
</DOC>